Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
维奈托克、苯达莫司汀和利妥昔单抗治疗复发或难治性非霍奇金淋巴瘤患者:一项 Ib 期剂量探索研究
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdy256
de Vos, S; Swinnen, L J; Wang, D; Reid, E; Fowler, N; Cordero, J; Dunbar, M; Enschede, S H; Nolan, C; Petrich, A M; Ross, J A; Salem, A H; Verdugo, M; Agarwal, S; Zhou, L; Kozloff, M; Nastoupil, L J; Flowers, C R